AIM ImmunoTech Inc. reports positive data from Phase 2a study evaluating Ampligen as a part of a regimen for treating colorectal cancer metastatic to the liver

AIM ImmunoTech Inc. reports positive data from Phase 2a study evaluating Ampligen as a part of a regimen for treating colorectal cancer metastatic to the liver
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.